Preferential use of nonreversed vein grafts in above-knee femoropopliteal bypasses for critical ischemia: midterm outcome.

We evaluated nonreversed vein grafts in above-knee bypasses for chronic critical limb ischemia in a retrospective study with intention-to-treat analysis in patients who underwent above-knee bypass grafting. During a 4-year period, 51 patients (men, 32; women, 19; mean age = 66 years) with 53 critically ischemic lower extremities underwent above-knee femoropopliteal bypass grafting. The follow-up evaluation consisted of clinical examination, assessment of the ankle-brachial systolic blood pressure index, and, whenever necessary, duplex scanning. Three (5.7%) deaths occurred within 30 days, two from myocardial infarction and one from an undetermined cause. The 2-year cumulative success rate was 82.5 ± 9.6% for primary patency, 84.6 ± 8.9% for secondary patency, 90.1 ± 7.3% for tertiary patency, 86.9 ± 7.6% for limb salvage, 77.7 ± 8.4% for survival, 68.0 ± 11.1% for composite patency, and 68.4 ± 9.3% for amputation-free survival; the corresponding estimates for vein grafts alone were 86.6 ± 9.2%, 88.9 ± 8.6%, 89.0 ± 8.5%, 88.1 ± 8.1%, 81.1 ± 9.1, 76.8 ± 11.1%, and 72.6 ± 10.2%. Three prosthetic grafts failed and were replaced with an arm vein graft. Nonreversed vein bypass grafts in above-knee revascularization of critically ischemic limbs are justified.